TSPO and Alzheimer disease: In mouse models of AD, we and others have shown that TSPO-targeted ligands are protective, reducing the accumulation of the toxic beta amyloid peptide (Aβ), which forms extracellular aggregates in the AD brain [6, 16, 32].